Co-Exclusivity. The license is Co-Exclusive, including the right to sublicense pursuant to Article 13, in the Licensed Field of Use for a term beginning on the Effective Date, and ending, on a country-by-country basis, on the expiration of the last to expire of Licensed Patents.
Appears in 6 contracts
Samples: Confidential Treatment (Isis Pharmaceuticals Inc), Strategic Collaboration and License Agreement (Alnylam Pharmaceuticals, Inc.), Collaboration and License Agreement (Alnylam Pharmaceuticals Inc)